Company: EUDAW
Filing Date: 2025-04-29
Form Type: 20-F
Source: 0001641172-25-006627
Chunk: 66

Company: EUDA Health Holdings Ltd
Filing Date: 2025-04-29
Form: 20-F
Item: Item 7
Chunk 66
---
 and accrued interests at 8% per annum (the “ James Tan Loan”). Pursuant to a
Settlement Agreement between the Company and Mr. Tan dated March 15, 2024 (the “ James Tan Settlement Agreement”), the Company
has agreed to issue Mr. Tan a convertible note in the aggregate amount of $24,004 (the “ James Tan Convertible Note”) in full
satisfaction of the James Tan Loan, and Mr. Tan has agreed to (i) exchange James Tan Loan for the James Tan Convertible Note; (ii) extend
the maturity date of the James Tan Loan to March 14, 2025; and (iii) allow the outstanding unpaid balance of the James Tan Loan to bear
no interest for the next twelve months until March 14, 2025.

Since May 15, 2023, 8i Enterprises
Pte Ltd (“8iEPL), a company owned by Mr. Tan, has been rendering certain advisory services for the Company. Pursuant to a certain
Settlement Agreement between the Company and 8iEPL dated March 15, 2024 (the “8iEPL Settlement Agreement”), the Company has
agreed to pay 8iEPL for a total sum of $180,000 for such advisory services (the “ Services Payment”). Between May 15, 2023
and February 28, 2024, the Company has borrowed from 8iEPL an aggregate amount of $712,254, or a total of $731,373 with unpaid and accrued
interests at 8% per annum (the “8iEPL Loan”). Pursuant to the 8iEPL Settlement Agreement, the Company has agreed to pay 8iEPL
in full satisfaction of both the Services Payment and the 8iEPL Loan in the form a convertible note in the aggregate amount of $911,373
(the “8iEPL Convertible Note”).

Any principal amount and accrued
interests under the James Tan Convertible Note and the 8iEPL Convertible Note may be converted into ordinary shares of the Company at
$1.27 per share (the “ Conversion Shares”) at the payee’s option at any time and from time to time, and the Company has
agreed to file a registration statement for the resale of the Conversion Shares no later than 30 days following the receipt of the payee’s
conversion notice.

On April